Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 41542/0001.
Bramox tablets
Bramox 2.5 mg tablets
Bramox 5 mg tablets
Bramox 10 mg tablets
Midodrine hydrochloride
1. What Bramox tablets are and what they are used for
2. What you need to know before you take Bramox tablets
3. How to take Bramox tablets
4. Possible side effects
5. How to store Bramox tablets
6. Contents of the pack and other information
The name of your medicine is Bramox tablets. They contain the medicine midodrine hydrochloride. This belongs to a group of medicines called adrenergic and dopaminergic agents.
Midodrine hydrochloride is a medicine that raises your blood pressure and is used to treat certain severe forms of low blood pressure in adults when other treatments have not worked.
Talk to your doctor or pharmacist before taking this medicine if you have been told you have high blood pressure when you lie down. If this applies to you then:
Also talk to your doctor if you:
You should have your kidney function and blood pressure checked by your doctor before you start using this medicine. During treatment with this medicine, your blood pressure will be checked from time to time, and if necessary your dose adjusted.
It is important that you immediately report symptoms related to high blood pressure, such as chest pain, palpitations, shortness of breath, headache and blurred vision. Your doctor will then decide whether to adjust dosage or discontinue your treatment with Bramox tablets.
If any of the warnings apply to you, or have in the past, talk to your doctor.
Do not give this medicine to children and adolescents under the age 18 because the safety and efficacy of Bramox tablets in this age group have not been established.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following:
Using this medicine while pregnant is not recommended, or if you are a woman of childbearing potential not using contraception. Tell your doctor if you are pregnant, or want to be, while you are being treated with this medicine.
Do not use this medicine while breast-feeding.
This medicine should not affect your ability to drive or use machines. However, you must be careful if dizziness or light-headedness occurs after taking this medicine.
Sunset Yellow FCF aluminium lake (E110) can cause allergic reactions.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Swallow tablets with a drink of water.
This medicine may be taken with or without food.
The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
Your doctor will decide your dose and tell you how long you should take this medicine. The treatment is usually long-term.
The recommended starting dose is normally one tablet of 2.5 mg three times a day. This dose can be increased weekly up to 10 mg three times daily, which is the usual maintenance dose of 30 mg per day.
The recommended total daily dose should be spread evenly into three doses per day.
Avoid taking this medicine in the late evening. The last dose should be taken at least 4 hours before your bedtime. Elevating your head at night reduces the potential risk of high blood pressure when you lie down. More information can be found in the section “Warnings and precautions” of this leaflet.
If you feel that the effect of this medicine is too strong, or too weak, talk to your doctor or pharmacist.
If you have used too much of this medicine please contact your doctor or pharmacist immediately.
Taking too much of this medicine can cause:
If you forget to take a dose, take your next dose as usual and then keep taking your medicine as your doctor has told you. Do not take a double dose to make up for a forgotten dose, because this will increase the risk of high blood pressure when you lie down.
There will be no sudden drop in your blood pressure.
Always talk to your doctor if you are considering stopping taking this medicine.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Bramox tablets can cause side effects, although not everybody gets them.
Very common (may affect more than 1 in 10 people):
Common (may affect more than 1 in 100 but less than 1 in 10 people):
Uncommon (may affect more than 1 in 1,000 but less than 1 in 100 people):
Rare (may affect more than 1 in 10,000 but less than 1 in 1,000 people):
Not known (frequency cannot be estimated from the available data):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (Website: www.mhra.gov.uk/yellowcard) or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the outer carton and on the blister foil. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. This will help to protect the environment.
The 2.5 mg tablets are white, round tablets marked on one side with “MID” above the score line and “2.5” below the score line.
The 5 mg tablets are orange, round tablets marked on one side with “MID” above the score line and “5” below the score line.
The 10 mg tablets are blue, round tablets marked “APO” on one side and “MID” above the score line and “10” below the score line on the other side.
This medicine is available in cartons of 50 or 100 tablets in aluminium/aluminium blister packs.
Not all pack sizes may be marketed.
This medicinal product is authorised in the Member States of the EEA under the following names:
Netherlands: Midodrine HCl Brancaster 2,5 mg tabletten, Midodrine HCl 5 mg tabletten and Midodrine HCl Brancaster 10 mg tabletten
Denmark, Norway, Sweden: Hypotron 2,5 mg tabletter, Hypotron 5 mg tabletter and Hypotron 10 mg tabletter
Finland: Hypotron 2,5 mg tabletit, Hypotron 5 mg tabletit and Hypotron 10 mg tabletit
Iceland: Hypotron 2,5 mg töflur. Hypotron 5 mg töflur and Hypotron 10 mg töflur
UK: Bramox 2.5 mg tablets, Bramox 5 mg tablets and Bramox 10 mg tablets
This leaflet was last revised in 12-2021
Detailed information on this medicine is available on the Medicines and Healthcare Products Regulatory Agency (MHRA) website: http://www.mhra.gov.uk